dm2023-0010 - 2022 Hospital Scorecard Rating Scale Only PDF

Download as pdf or txt
Download as pdf or txt
You are on page 1of 4

Annex’A:,

2022 Hospital Scorecard Rating Scale

Target Rating Scale


Indicator Formula/ Operational Definition Range of. the Actual
2022 Score
Accomplishment

100% 0,
5
Numerator: Number of patients in basic
accommodation with zero co-payment
Indicator 1. Denominator: Total number of patients in 95.00% - 99.99% 4

IPC
basic accommodation

_for
% patients in basic
100%
accommodation with
: .

zero co-payment . .
90.00% - 94.99% 3
*Basic accommodation refers to ward
accommodation. This indicator measures how
many patients in basic/ward accommodation are
with zero co-payment or No-Balance Billing. 89.99% and below 2

5
Numerator: Number of PhilHealth claims

personne]
returned to hospital
Level 1 Will not be 4
and 2: included in the
Denominator: Total number of PhilHealth
. 2022 Hospital
claims processed and returned to hospital +
:

3
<6% Scorecard
2.
;
claims processed and paid by PhilHealth
: :

Indicator
2
% of Returned-to *% of RTH claims isthe percentage of PhilHealth
claims which were returned to the hospital due to
Hospital of the
some deficiency with certain requirements, 5
PhilHealth claims
among all
the PhilHealth claims processed.
Will not be
3: 4
in
Level .
EXCLUSION: included the
1. Auto-rejected claims (which the hospital °
2022 Hospital
will identify and provide documentation) <2% 3
Scorecard
2. All COVID-19 laboratory procedures
claims 2

Numerator: Number of ER Patients with <4 100% 5


hours Turnaround Time
Denominator: Total number of patients who
were received in the ER
Indicator 3. 95.00% - 99.99% 4

4%
of ER Patients with <
, .
*ER TAT
is defined as the time interval from the
time the patient is received in the ER up to the
100%
4 hours Turnaround time the patient is released (admitted
Time /discharged), minus the time spent by the medical 90.00% - 94.99% 3

_donning/doffing/other
rocedures when to the
attending patient.
The decision to admit/discharge may not reflect
the actual transfer of the patients from the ER to
wards/rooms. DOA is excluded
but ER deaths are included.
in
this indicator, 89.99% and below 2
as
95.00% - 100%

Numerator: Number of patients with <4


hours Discharge Process Turnaround Time
Indicator 4. Denominator: Total number of patients 90.25% - 94.99%
% of patients with<4 ‘discharged
:
°
95%
hours Discharge Process
*Disch
ischarge P Process TAT is defined as the titime
is

defined
Turnaround Time
the

interval between discharge order of the doctor 85.50% - 90.24%


and the actual discharge of the patient. Deaths are
not included in this indicator

85.49% and below

Numerator: Total number of inpatients who


had infection after 48 hours upon admission
Denominator: . Total number of discharges
. : 0% - 0.99%
Indicator 5. and deaths occurring after 48 hours upon
.
admission during the same year
<1%
/

Hospital Acquired
Infection Rate (%) *Based on General Appropriations Act 2021
DOH Commitment with a target of <I% for
Hospital Acquired Infection Rate. Including all 1.00% and above
types of HAI (Device- VAP, CLABSI, CAUTI;
and Non-device-SSI)

Numerator: No. of inpatient laboratory test 95.00% - 100%


results with < 5 hours Turnaround Time
Denominator: Total number of
inpatient
laboratory tests
.
Indicator 6. 90.25% - 94.99%
j : *Laboratory test results TAT is defined as the
%
%
inpatient
of of
time interval between the doctor’s order request
laboratory test result in the chart and the release of results.
°
95%
with < 5 hours Inclusion: Scope of lab tests- routine clinical and
85.50% - 90.24%
Turnaround Time hematologic lab tests only (CBC, Platelet Count,
aPTT, FBS, Na, K, Creatinine, UA, BUN, Total
Cholesterol, HDL, LDL, Triglyceride, SGOT,
SGPT, Urinalysis)
Exclusion: Histopathologic and microbiological
85.49% and below
°,

test requests, other lab tests which require fasting

ISO 2015
accreditation
+ PGS (Stage 2 or
.
Indicator 7. PGs
any stages above)
seas aoa: and/or other
Accreditation to ISO, Accreditation of the hospital to ISO, PGS, or :
:

Complian international
PGS or international
ses
any international accreditation body ce Stage «att
accreditation
accrediting body (Stage 2)

ISO 2015
accreditation + PGS
Stage 1
ISO 2015
accreditation +
Attended the PGS
module/bootcamp
but not yet initiated

ISO 2015
accreditation only
(No PGS accreditation)

Or

PGS accreditation
(Stage 1 or any
stage) only
(No ISO 2015
accreditation)

Attended the PGS


module/bootcamp
but not yet
initiated only
(No ISO 2015
accreditation)

No ISO 2015
accreditation + No
PGS accreditation

The overall score in the Report Card Survey


which reflects results in terms of two core Will not be
Indicator 8. areas: included in the
95%°
Report Card Survey : vos 2022 Hospital
(1) Compliance with ARTA Provisions and
:

(RCS) Scores Scorecay d


(2) Overall Client Satisfaction.

4 or more
researches

3 researches
Total number of clinical or operational
improvement research output which are: Level 1
and 2: .

1. Funded by the
hospital, or; 2 researches
2. Presented to a _local/international 4
Indicator 9.
Research output
consortium and conference (including
hospital and intradepartmental consortia) I research

*Must satisfy at least 1 of the given criteria for No research


the research to be counted.
**Published case study/series (unique or rare
case) are counted as researches. 9 or more
Level 3: researches

9
7-8 researches
5-6 researches 3

3-4 researches 2

0-2 researches 1

Submitted by:

MA. THERESA
Director IV
&. YERA, MD, MSc, MHA, CESO
III
Health Facility Development Bureau

Concurred by:

ENRIQUE

North Luzon
pf
Undersecretary of Heal
PHSAE, FPSMID, CESO

Field Implementation and Coordination Team (FICT)-


III NESTOR
F. SANTIAGO, JR., MD, MPHC, MHSA, CESO II
Undersecretary of Health
Field Implementation and Coordination Team (FICT)-
NCR
and South Luzon

CAMILO
Undersecretary ofHealth
SCOLAN, MPM, CESE ABDULLAH B. D
Undersecretary of Healt
, JR., MD, MPA, CESO I

Field Implementation and Coordination Team (FICT)- Field Implementation an¥ Yoordination Team (FICT)-
Visayas Mindanao

Approved by:

UA J
LILIBETH C. DAVID, MD, MPH, MPM, CESO I
Undersecretary of Health
Health Policy and Infrastructure Devetopment Team

You might also like